HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys Ruchika Sharma26 Oct 2023 4:21 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...
GSK HIV prevention drug gets European Commission authorisation Ruchika Sharma19 Sept 2023 2:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
Shionogi seeks Japenese nod for COVID Recombinant Protein-based Vaccine S-268019 Ruchika Sharma27 Nov 2022 1:30 PM ISTOsaka: Shionogi & Co., Ltd. has announced that it has filed for manufacturing and sales approval of S-268019, a recombinant protein-based...
ViiV Healthcare Cabotegravir long-acting injectable for HIV prevention gets EMA validation Ruchika Sharma30 Oct 2022 11:45 AM ISTCabotegravir long-acting for PrEP is an integrase strand transfer inhibitor (INSTI).
COVID pill S-217622 shows rapid clearance of virus: Shionogi Ruchika Sharma25 April 2022 10:00 AM ISTThe company has global aspirations for the antiviral pill, which is now being evaluated by Japanese regulators.
GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 mln savita thakur thakur19 Dec 2015 1:05 PM ISTLondon: Pharmaceutical group GlaxoSmithKline said its majority-owned HIV drugs business would buy drugs at different stages of development from U.S....
